# Serological Response to Antipneumococcal Vaccination and Impact on Streptococcus Pneumoniae Nasal Carriage in HIV Adults

> **NCT02123433** · PHASE3 · COMPLETED · sponsor: **University of Siena** · enrollment: 50 (actual)

## Conditions studied

- HIV Infection
- Pneumococcal Infections

## Interventions

- **BIOLOGICAL:** pneumococcal conjugate 13 valent vaccine

## Key facts

- **NCT ID:** NCT02123433
- **Lead sponsor:** University of Siena
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-12
- **Primary completion:** 2013-10
- **Final completion:** 2013-10
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2014-04-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02123433

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02123433, "Serological Response to Antipneumococcal Vaccination and Impact on Streptococcus Pneumoniae Nasal Carriage in HIV Adults". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02123433. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*